Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Malignant Neoplasm of Bladder: early-phase trial registry

1 of 1 indexed Malignant Neoplasm of Bladder trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Malignant Neoplasm of Bladder: 1 US clinical trial tracked, 1 recruiting.

Malignant Neoplasm of Bladder is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Case Comprehensive Cancer Center, running 1 of these trials.

Enrollment posture brief

Registry condition malignant-neoplasm-of-bladder

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Malignant Neoplasm of Bl (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Malignant Neoplasm of Bladder

Malignant Neoplasm of Bladder lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Malignant Neoplasm of Bladder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Malignant Neoplasm of Bladder is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Malignant Neoplasm of Bladder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Adjuvant systemic therapy Drug
1 trials
Partial cystectomy with Extended pelvic lymph node dissection Procedure
1 trials
Neoadjuvant Chemotherapy Drug
1 trials

US sites by state

Facility locations filed on Malignant Neoplasm of Bladder trials. A trial with sites in several states counts in each.

Ohio 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Malignant Neoplasm of Bladder page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Malignant Neoplasm of Bladder condition card totals 1 registered trials; most-linked intervention Adjuvant systemic therapy; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.